Hasan Cem Irkilata
Research Subjects
Hasan Cem Irkilata has a total of 164 co-authors. Here are the top co-authors by number of shared publications:
Murat Dayanc
Gulhane Military Medical Academy, Etlik, Ankara, Turkey
17 shared publicationsYusuf Kibar
Korea Hospital, Department of Urology, Ankara, Turkey
17 shared publicationsIbrahim Yildirim
Gulhane Medical Academy
10 shared publicationsSeref Basal
Gülhane Military Medical Academy
10 shared publicationsEmin Aydur
9 shared publications- Murat Dayanc
Division of Pediatric Urology, Private Dayanc Urology Center, Ankara, Turkey
6 shared publications
Latest Publications
- 7 September 2026
- Published by Wiley in Neurourology and Urodynamics
Pelvic Floor Dysfunctions in Children With Lower Urinary Tract Dysfunction and Relationship With Urine Flow
Purpose: Pelvic floor muscle (PFM) dynamics play a significant role alongside bladder and rectal dynamics in the pathophysiology of lower urinary tract dysfunction (LUTD) in children. This study aimed to determine PFM activities (PFMA), including resting tone and contractile functions, of LUTD subtypes in children according to their voiding patterns. Materials and Methods: 160 children presenting to our clinic with symptoms of lower pelvic floor voiding (LUTD) were evaluated using noninvasive diagnostic methods, and LUTD subtypes were determined. Based on voiding patterns, 31 had intermittent, 59 had staccato, 28 had tower, 31 had bell and 11 had plateau voiding pattern. 18 healthy children served as a control group and also exhibited bell curve voiding. PFMA was measured using superficial electrodes after voiding. Children performed five cycles of 5‐s relaxation followed by 5‐s voluntary PFM contraction, resulting in a total recording period of 50 s. Mean relaxation and contraction EMG values were recorded for analysis. According to PFMA measurements, pelvic floor dysfunction (PFD) subtypes defined and frequencies determined. Results: According to the LUTD subtype, the frequency of pelvic floor overactivity (PFO) ranged from 59% to 86%, and the overall frequency of contractile dysfunctions (Nonfunctional or weak functional pelvic floor) ranged from 64% to 78%. As the voiding pattern improved, the resting tone decreased and normalized, thus the frequency of PFO reduced from 84% to 45% ( p = 0.0001). Conclusions: The measurement of PFMA enables the identification of PFD subtypes in children with LUTD. The pathophysiology of LUTD can be better understood noninvasively.
- 7 September 2026
- Published by Wiley in Neurourology and Urodynamics
Pelvic Floor Dysfunctions in Children With Lower Urinary Tract Dysfunction and Relationship With Urine Flow
Purpose: Pelvic floor muscle (PFM) dynamics play a significant role alongside bladder and rectal dynamics in the pathophysiology of lower urinary tract dysfunction (LUTD) in children. This study aimed to determine PFM activities (PFMA), including resting tone and contractile functions, of LUTD subtypes in children according to their voiding patterns. Materials and Methods: 160 children presenting to our clinic with symptoms of lower pelvic floor voiding (LUTD) were evaluated using noninvasive diagnostic methods, and LUTD subtypes were determined. Based on voiding patterns, 31 had intermittent, 59 had staccato, 28 had tower, 31 had bell and 11 had plateau voiding pattern. 18 healthy children served as a control group and also exhibited bell curve voiding. PFMA was measured using superficial electrodes after voiding. Children performed five cycles of 5‐s relaxation followed by 5‐s voluntary PFM contraction, resulting in a total recording period of 50 s. Mean relaxation and contraction EMG values were recorded for analysis. According to PFMA measurements, pelvic floor dysfunction (PFD) subtypes defined and frequencies determined. Results: According to the LUTD subtype, the frequency of pelvic floor overactivity (PFO) ranged from 59% to 86%, and the overall frequency of contractile dysfunctions (Nonfunctional or weak functional pelvic floor) ranged from 64% to 78%. As the voiding pattern improved, the resting tone decreased and normalized, thus the frequency of PFO reduced from 84% to 45% ( p = 0.0001). Conclusions: The measurement of PFMA enables the identification of PFD subtypes in children with LUTD. The pathophysiology of LUTD can be better understood noninvasively.
- 18 August 2026
- Published by Wiley in Neurourology and Urodynamics
Multimodal Therapy for Monosymptomatic Nocturnal Enuresis: Nocturnal Bladder and Pelvic Floor Dynamics
Objective: This study aimed to evaluate pelvic floor muscle activity (PFMA) in children with monosymptomatic nocturnal enuresis (MNE) and to investigate the effectiveness of multimodal treatment including standard urotherapy, alarm therapy, and pelvic floor muscle rehabilitation (PFMR) approach by assessing nocturnal bladder and pelvic floor dynamics. Methods: In this retrospective cross‐sectional study, medical records of children with primary MNE were reviewed. All participants received a multimodal treatment consisting of (i) standard urotherapy based on International Children's Continence Society recommendations, (ii) enuresis alarm therapy with objective nocturnal urine volume monitoring, and (iii) individualized PFMR. PFMR was designed according to baseline PFMA assessed objectively using surface electromyography and included relaxation‐oriented interventions for pelvic floor overactivity, coordination training, and strength and endurance exercises integrated with core muscles. Nocturnal bladder dynamics, PFMA parameters, and treatment outcomes were retrospectively analyzed. Treatment response was classified as complete, partial, or no response. Results: A total of 65 children were included. At baseline, 67.7% of children had pelvic floor overactivity, and 64.7% had nonfunctional or weak functional pelvic floor. Both pelvic floor dysfunctions coexisted in 25 children (38%). During multimodal therapy, objective nocturnal measures demonstrated a significant reduction in alarm activations and diaper urine volume, alongside increased voided volumes (all p < 0.001). Resting tone, contraction and functional contraction amplitude were significantly improved after treatment (all p < 0.001). Complete response was achieved in 75.4% of children at 12 weeks and increased to 93.8% at 16 weeks. Conclusion: Multimodal treatment combining standard urotherapy, alarm therapy with individualized PFMR based on objective PFMA assessment appears highly effective in children with MNE and may optimize both pelvic floor function and nocturnal bladder dynamics.
- 18 August 2026
- Published by Wiley in Neurourology and Urodynamics
Multimodal Therapy for Monosymptomatic Nocturnal Enuresis: Nocturnal Bladder and Pelvic Floor Dynamics
Objective: This study aimed to evaluate pelvic floor muscle activity (PFMA) in children with monosymptomatic nocturnal enuresis (MNE) and to investigate the effectiveness of multimodal treatment including standard urotherapy, alarm therapy, and pelvic floor muscle rehabilitation (PFMR) approach by assessing nocturnal bladder and pelvic floor dynamics. Methods: In this retrospective cross‐sectional study, medical records of children with primary MNE were reviewed. All participants received a multimodal treatment consisting of (i) standard urotherapy based on International Children's Continence Society recommendations, (ii) enuresis alarm therapy with objective nocturnal urine volume monitoring, and (iii) individualized PFMR. PFMR was designed according to baseline PFMA assessed objectively using surface electromyography and included relaxation‐oriented interventions for pelvic floor overactivity, coordination training, and strength and endurance exercises integrated with core muscles. Nocturnal bladder dynamics, PFMA parameters, and treatment outcomes were retrospectively analyzed. Treatment response was classified as complete, partial, or no response. Results: A total of 65 children were included. At baseline, 67.7% of children had pelvic floor overactivity, and 64.7% had nonfunctional or weak functional pelvic floor. Both pelvic floor dysfunctions coexisted in 25 children (38%). During multimodal therapy, objective nocturnal measures demonstrated a significant reduction in alarm activations and diaper urine volume, alongside increased voided volumes (all p < 0.001). Resting tone, contraction and functional contraction amplitude were significantly improved after treatment (all p < 0.001). Complete response was achieved in 75.4% of children at 12 weeks and increased to 93.8% at 16 weeks. Conclusion: Multimodal treatment combining standard urotherapy, alarm therapy with individualized PFMR based on objective PFMA assessment appears highly effective in children with MNE and may optimize both pelvic floor function and nocturnal bladder dynamics.
- 20 April 2019
- Published by Wiley in Neurourology and Urodynamics
- Vol. 38 (5) , 1430-1442
The effects of pelvic floor muscle therapy on symptoms, voiding, and pelvic floor muscle activity parameters in children with overactive bladder
Introduction: Refractory overactive bladder (OAB) in children can be treated with second line modalities such as as biofeedback, transcutaneous electrical stimulation (TENS), and botulinum toxin. In this study, we aimed to investigate the efficacy of biofeedback‐assisted pelvic floor muscle therapy (PFMT) on symptoms, bladder capacity, uroflowmetry, and pelvic floor muscle activity (PFMA) in children with resistant OAB or dysfunctional voiding (DV) with associated seconder bladder overactivity (DV/SBO).Materials and Methods: A total of 24 children with resistant OAB were included in the study. Patients were divided into two groups as: group‐1 pure OAB and group‐2 DV/SBO. Children were evaluated with voiding diary, uroflowmetry‐EMG, PFMA before and after treatment. All patients were treated with PFMT.Results: Urgency cured or improved in 12 of 17 (71%) of children in group‐1 and in six of seven (86%) children in group‐2 (P < 0.0001 and 0.031, respectively). Other symptoms cured or improved with 64%‐100% recovery rates in group‐1 and 50%‐80% in group‐2. Maximum voided volume (maxVV) in voiding diary increased from 81.6 to 150.9 mL in group‐1 and from 115.6 to 175.7 mL in group‐2 (P < 0.0001 and 0.063, respectively). Mean work value of PFMA increased and mean rest value of PFMA decreased significantly (P < 0.0001, 0.018 and P = 0.002 and 0.018, respectively).Conclusion: The measurement of PFMA in children with refractory OAB or DV/SBO gives information on the strength and endurance of PFMs. In children with refractory OAB or DV/SBO, biofeedback‐assisted PFMT provides symptomatic improvement and increases functional bladder capacity.
- 20 April 2019
- Published by Wiley in Neurourology and Urodynamics
- Vol. 38 (5) , 1430-1442
The effects of pelvic floor muscle therapy on symptoms, voiding, and pelvic floor muscle activity parameters in children with overactive bladder
Introduction: Refractory overactive bladder (OAB) in children can be treated with second line modalities such as as biofeedback, transcutaneous electrical stimulation (TENS), and botulinum toxin. In this study, we aimed to investigate the efficacy of biofeedback‐assisted pelvic floor muscle therapy (PFMT) on symptoms, bladder capacity, uroflowmetry, and pelvic floor muscle activity (PFMA) in children with resistant OAB or dysfunctional voiding (DV) with associated seconder bladder overactivity (DV/SBO).Materials and Methods: A total of 24 children with resistant OAB were included in the study. Patients were divided into two groups as: group‐1 pure OAB and group‐2 DV/SBO. Children were evaluated with voiding diary, uroflowmetry‐EMG, PFMA before and after treatment. All patients were treated with PFMT.Results: Urgency cured or improved in 12 of 17 (71%) of children in group‐1 and in six of seven (86%) children in group‐2 (P < 0.0001 and 0.031, respectively). Other symptoms cured or improved with 64%‐100% recovery rates in group‐1 and 50%‐80% in group‐2. Maximum voided volume (maxVV) in voiding diary increased from 81.6 to 150.9 mL in group‐1 and from 115.6 to 175.7 mL in group‐2 (P < 0.0001 and 0.063, respectively). Mean work value of PFMA increased and mean rest value of PFMA decreased significantly (P < 0.0001, 0.018 and P = 0.002 and 0.018, respectively).Conclusion: The measurement of PFMA in children with refractory OAB or DV/SBO gives information on the strength and endurance of PFMs. In children with refractory OAB or DV/SBO, biofeedback‐assisted PFMT provides symptomatic improvement and increases functional bladder capacity.
- 15 March 2019
- Published by Elsevier in European Urology Supplements
- Vol. 18 (1) , e926-e927
The effects of pelvic floor muscle rehabilitation (PFMR) on symptoms, voiding and pevic floor muscle parameters in children with overactive bladder
- 15 March 2019
- Published by Elsevier in European Urology Supplements
- Vol. 18 (1) , e926-e927
The effects of pelvic floor muscle rehabilitation (PFMR) on symptoms, voiding and pevic floor muscle parameters in children with overactive bladder
- 1 December 2018
- Published by Galenos Yayinevi in Journal of Urological Surgery
- Vol. 5 (4) , 217-220
Scrotal Tissue Necrosis in a Patient with Urethral Stricture Treated with Internal Urethrotomy and Mitomycin-C Injection
- 1 December 2018
- Published by Galenos Yayinevi in Journal of Urological Surgery
- Vol. 5 (4) , 217-220
Scrotal Tissue Necrosis in a Patient with Urethral Stricture Treated with Internal Urethrotomy and Mitomycin-C Injection
- 1 December 2018
- Published by Galenos Yayinevi in Journal of Urological Surgery
- Vol. 5 (4) , 176-181
Assessment of Serotonin Metabolite 5-hydroxyindoleacetic Acid Levels in Urine Sample for Diagnosis and Treatment Efficacy in Children with Dysfunctional Voiding and Their Interaction with Biofeedback Therapy
- 1 December 2018
- Published by Galenos Yayinevi in Journal of Urological Surgery
- Vol. 5 (4) , 176-181
Assessment of Serotonin Metabolite 5-hydroxyindoleacetic Acid Levels in Urine Sample for Diagnosis and Treatment Efficacy in Children with Dysfunctional Voiding and Their Interaction with Biofeedback Therapy
- Open Access
- 1 November 2017
- Published by Canadian Urological Association Journal in Canadian Urological Association Journal
- Vol. 11 (11) , E441-5
The histopathological effects of intracavernosal mitomycin-C injection in a rat Peyronie's disease model
Introduction: We aimed to evaluate whether or not nitomycin-C (MMC) has an anti-fibrotic effect on transforming growth factor beta (TGF-β)-induced Peyronie's disease (PD) in a rat model. Methods: Eighteen 12-week-old male Sprague-Dawley rats were divided into three groups: Group 1= TGF-β1 (n:7); Group 2= TGF-β1+MMC (n:7); and Group 3= Sham group (0.25 ml bovine serum albumin injected) (n:4). All groups were sacrificed on the sixthweek of the procedure and their penises were excised. All penis specimens were evaluated semi-quantitatively and quantitatively with histochemical, immunohistochemistry and image analysis. Results: Both Group 1 and Group 2 had significantly higher fibrosis scores and lower elastic fibers in both outer surface of tunica albuginea (TA) and subsinusoidal area compared with Group 3. When compared with Group 1, the amount of collagen was significantly decreased in Group 2. Intracavernosal MMC injection (Group 2) ended up with lower elastic fibers when compared with Group 1. According to the quantitative analyses, when compared with Groups 1and 3, lower dorsal, ventral, and trabecular thickening values were seen in Group 2. These parameters were only statistically significant when compared with Group 1, suggesting the anti-fibrotic effect of TGF-β1-induced fibrosis. Both Groups 1 and 2 showed lower decorin staining levels in SATA and SATW when compared with Group 3. The statistically significant difference was only detected between Group 1 and Group 3. Conclusions: Our study demonstrates the anti-fibrotic effects of MMC on PD. Further clinical studies are necessary to make inferences regarding its clinical use.
- 1 November 2017
- Published by Canadian Urological Association Journal in Canadian Urological Association Journal
- Vol. 11 (11) , E441-5
Open AccessThe histopathological effects of intracavernosal mitomycin-C injection in a rat Peyronie's disease model
Introduction: We aimed to evaluate whether or not nitomycin-C (MMC) has an anti-fibrotic effect on transforming growth factor beta (TGF-β)-induced Peyronie's disease (PD) in a rat model. Methods: Eighteen 12-week-old male Sprague-Dawley rats were divided into three groups: Group 1= TGF-β1 (n:7); Group 2= TGF-β1+MMC (n:7); and Group 3= Sham group (0.25 ml bovine serum albumin injected) (n:4). All groups were sacrificed on the sixthweek of the procedure and their penises were excised. All penis specimens were evaluated semi-quantitatively and quantitatively with histochemical, immunohistochemistry and image analysis. Results: Both Group 1 and Group 2 had significantly higher fibrosis scores and lower elastic fibers in both outer surface of tunica albuginea (TA) and subsinusoidal area compared with Group 3. When compared with Group 1, the amount of collagen was significantly decreased in Group 2. Intracavernosal MMC injection (Group 2) ended up with lower elastic fibers when compared with Group 1. According to the quantitative analyses, when compared with Groups 1and 3, lower dorsal, ventral, and trabecular thickening values were seen in Group 2. These parameters were only statistically significant when compared with Group 1, suggesting the anti-fibrotic effect of TGF-β1-induced fibrosis. Both Groups 1 and 2 showed lower decorin staining levels in SATA and SATW when compared with Group 3. The statistically significant difference was only detected between Group 1 and Group 3. Conclusions: Our study demonstrates the anti-fibrotic effects of MMC on PD. Further clinical studies are necessary to make inferences regarding its clinical use.
- 1 October 2017
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-4
Classification of uroflowmetry and EMG signals of pediatric patients using Artificial Neural Networks
UF-EMG test, in which non-invasive uroflowmetry (UF) and electromyography (EMG) signals are simultaneously recorded, is frequently used in children diagnosed with lower urinary tract dysfunction disease (AUSD) and its treatment. In the literature, independent (single) UF signals and integrated (dual) UF-EMG signals are graded many times but there is no classification study of UF-EMG integrated signals with Artificial Neural Networks (ANN), although studies have been done to classify UF signals with ANN. In this paper, it was aimed to classify the UF-EMG signals recorded from pediatric patients during the UF-EMG tests in Urodinami Center of Gülhane Education and Research Hospital using ANN. 773 (80%) of the 967 patients with an average age of 8 were used for training and 194 (20%) were used for the test. In YSA, the contribution of the features obtained from the EMG signals played a crucial role and was the main reason to improve the signal classification from 58% to 84.02%. The new classification method created by the obtained data does facilitate the interpretation of UF-EMG results for the clinical personnel in diagnosis, follow-up and treatment of patients. It is also aimed that the pediatric patients living in regions with less access to health care can be treated by providing an early and easy preliminary diagnostic tool.
- 1 October 2017
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-4
Classification of uroflowmetry and EMG signals of pediatric patients using Artificial Neural Networks
UF-EMG test, in which non-invasive uroflowmetry (UF) and electromyography (EMG) signals are simultaneously recorded, is frequently used in children diagnosed with lower urinary tract dysfunction disease (AUSD) and its treatment. In the literature, independent (single) UF signals and integrated (dual) UF-EMG signals are graded many times but there is no classification study of UF-EMG integrated signals with Artificial Neural Networks (ANN), although studies have been done to classify UF signals with ANN. In this paper, it was aimed to classify the UF-EMG signals recorded from pediatric patients during the UF-EMG tests in Urodinami Center of Gülhane Education and Research Hospital using ANN. 773 (80%) of the 967 patients with an average age of 8 were used for training and 194 (20%) were used for the test. In YSA, the contribution of the features obtained from the EMG signals played a crucial role and was the main reason to improve the signal classification from 58% to 84.02%. The new classification method created by the obtained data does facilitate the interpretation of UF-EMG results for the clinical personnel in diagnosis, follow-up and treatment of patients. It is also aimed that the pediatric patients living in regions with less access to health care can be treated by providing an early and easy preliminary diagnostic tool.
- Open Access
- 10 November 2016
- Published by Canadian Urological Association Journal in Canadian Urological Association Journal
- Vol. 10 (11-12) , 395-7
Congenital anterior urethral diverticulum presenting as a scrotal mass in a two-year-old child
Here, we describe a case of congenital anterior urethral diverticulum (CAUD) in a two-year-old boy, who presented with right inguinoscrotal swelling that mimicked a spermatic cord cyst or hydrocele. Accurate diagnosis was made intraoperatively by retrograde urethrography. Open diverticulectomy and primary urethroplasty were performed for its management. The clinical presentation, diagnosis, and the management of this rare condition is discussed.
- 10 November 2016
- Published by Canadian Urological Association Journal in Canadian Urological Association Journal
- Vol. 10 (11-12) , 395-7
Open AccessCongenital anterior urethral diverticulum presenting as a scrotal mass in a two-year-old child
Here, we describe a case of congenital anterior urethral diverticulum (CAUD) in a two-year-old boy, who presented with right inguinoscrotal swelling that mimicked a spermatic cord cyst or hydrocele. Accurate diagnosis was made intraoperatively by retrograde urethrography. Open diverticulectomy and primary urethroplasty were performed for its management. The clinical presentation, diagnosis, and the management of this rare condition is discussed.
- 1 October 2016
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 12 (5) , 290.e1-290.e7
Biofeedback as a first-line treatment for overactive bladder syndrome refractory to standard urotherapy in children
- 1 October 2016
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 12 (5) , 290.e1-290.e7
Biofeedback as a first-line treatment for overactive bladder syndrome refractory to standard urotherapy in children